137.91 USD
+0.83 (+0.61%)
137.89 USD
-0.02 (-0.01%)
Taking everything into account, MASI scores 4 out of 10 in our fundamental rating. MASI was compared to 185 industry peers in the Health Care Equipment & Supplies industry. MASI has an average financial health and profitability rating. MASI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
MASI had positive earnings in the past year.
In the past year MASI had a positive cash flow from operations.
MASI had positive earnings in 4 of the past 5 years.
In the past 5 years MASI always reported a positive cash flow from operatings.
1.2 Ratios
MASI has a Return On Assets (-31.33%) which is in line with its industry peers.
MASI's Return On Equity of -70.30% is in line compared to the rest of the industry. MASI outperforms 44.32% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.63%, MASI belongs to the top of the industry, outperforming 88.65% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MASI is below the industry average of 8.84%.
The 3 year average ROIC (4.63%) for MASI is below the current ROIC(9.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.33% | ||
| ROE | -70.3% | ||
| ROIC | 9.63% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.63%
ROIC(5y)8.2%
1.3 Margins
The Operating Margin of MASI (10.29%) is better than 79.46% of its industry peers.
In the last couple of years the Operating Margin of MASI has declined.
With a Gross Margin value of 54.96%, MASI perfoms like the industry average, outperforming 53.51% of the companies in the same industry.
In the last couple of years the Gross Margin of MASI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.29% | ||
| PM (TTM) | N/A | ||
| GM | 54.96% |
OM growth 3Y-54.54%
OM growth 5Y-38.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
2. Health
2.1 Basic Checks
MASI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MASI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MASI remains at a similar level compared to 5 years ago.
MASI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 7.10 indicates that MASI is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.10, MASI belongs to the best of the industry, outperforming 83.24% of the companies in the same industry.
MASI has a debt to FCF ratio of 2.96. This is a good value and a sign of high solvency as MASI would need 2.96 years to pay back of all of its debts.
MASI has a better Debt to FCF ratio (2.96) than 83.78% of its industry peers.
MASI has a Debt/Equity ratio of 0.69. This is a neutral value indicating MASI is somewhat dependend on debt financing.
MASI's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. MASI is outperformed by 67.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 2.96 | ||
| Altman-Z | 7.1 |
ROIC/WACC1
WACC9.63%
2.3 Liquidity
MASI has a Current Ratio of 2.84. This indicates that MASI is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.84, MASI perfoms like the industry average, outperforming 55.14% of the companies in the same industry.
A Quick Ratio of 1.92 indicates that MASI should not have too much problems paying its short term obligations.
The Quick ratio of MASI (1.92) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
MASI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.77%, which is quite impressive.
MASI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.86% yearly.
MASI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.03%.
MASI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.43% yearly.
EPS 1Y (TTM)54.77%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%34.69%
Revenue 1Y (TTM)-16.03%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-26.44%
3.2 Future
The Earnings Per Share is expected to grow by 12.11% on average over the next years. This is quite good.
MASI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.10% yearly.
EPS Next Y30.61%
EPS Next 2Y18.45%
EPS Next 3Y16.36%
EPS Next 5Y12.11%
Revenue Next Year-27.11%
Revenue Next 2Y-11.76%
Revenue Next 3Y-5.71%
Revenue Next 5Y-1.1%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 24.28, MASI is valued on the expensive side.
81.08% of the companies in the same industry are more expensive than MASI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.00, MASI is valued at the same level.
A Price/Forward Earnings ratio of 22.96 indicates a rather expensive valuation of MASI.
78.38% of the companies in the same industry are more expensive than MASI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.70, MASI is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.28 | ||
| Fwd PE | 22.96 |
4.2 Price Multiples
MASI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MASI is cheaper than 70.81% of the companies in the same industry.
MASI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MASI is cheaper than 75.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.25 | ||
| EV/EBITDA | 32.93 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MASI's earnings are expected to grow with 16.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.79
PEG (5Y)4.15
EPS Next 2Y18.45%
EPS Next 3Y16.36%
5. Dividend
5.1 Amount
No dividends for MASI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
137.91
+0.83 (+0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners106.93%
Inst Owner Change0%
Ins Owners0.19%
Ins Owner Change1.07%
Market Cap7.41B
Revenue(TTM)1.72B
Net Income(TTM)-569.40M
Analysts81.25
Price Target187.2 (35.74%)
Short Float %7.83%
Short Ratio5.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.18%
Min EPS beat(2)6.64%
Max EPS beat(2)7.73%
EPS beat(4)4
Avg EPS beat(4)9.88%
Min EPS beat(4)6.64%
Max EPS beat(4)14.9%
EPS beat(8)8
Avg EPS beat(8)11.58%
EPS beat(12)12
Avg EPS beat(12)9.84%
EPS beat(16)16
Avg EPS beat(16)9.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.35%
Max Revenue beat(2)-0.8%
Revenue beat(4)0
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-1.35%
Max Revenue beat(4)-0.59%
Revenue beat(8)0
Avg Revenue beat(8)-1.1%
Revenue beat(12)1
Avg Revenue beat(12)-1.81%
Revenue beat(16)4
Avg Revenue beat(16)-1.23%
PT rev (1m)-0.48%
PT rev (3m)-1.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.06%
EPS NY rev (1m)0%
EPS NY rev (3m)2.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.28 | ||
| Fwd PE | 22.96 | ||
| P/S | 4.32 | ||
| P/FCF | 39.25 | ||
| P/OCF | 35.65 | ||
| P/B | 9.14 | ||
| P/tB | 11.35 | ||
| EV/EBITDA | 32.93 |
EPS(TTM)5.68
EY4.12%
EPS(NY)6.01
Fwd EY4.35%
FCF(TTM)3.51
FCFY2.55%
OCF(TTM)3.87
OCFY2.81%
SpS31.93
BVpS15.08
TBVpS12.15
PEG (NY)0.79
PEG (5Y)4.15
Graham Number43.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.33% | ||
| ROE | -70.3% | ||
| ROCE | 12.18% | ||
| ROIC | 9.63% | ||
| ROICexc | 12.27% | ||
| ROICexgc | 14.25% | ||
| OM | 10.29% | ||
| PM (TTM) | N/A | ||
| GM | 54.96% | ||
| FCFM | 11% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.63%
ROIC(5y)8.2%
ROICexc(3y)5.01%
ROICexc(5y)12.81%
ROICexgc(3y)9.36%
ROICexgc(5y)17.94%
ROCE(3y)5.86%
ROCE(5y)10.38%
ROICexgc growth 3Y-54.41%
ROICexgc growth 5Y-39.37%
ROICexc growth 3Y-57.67%
ROICexc growth 5Y-43.42%
OM growth 3Y-54.54%
OM growth 5Y-38.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
F-Score6
Asset Turnover0.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 2.96 | ||
| Debt/EBITDA | 2.41 | ||
| Cap/Depr | 34.11% | ||
| Cap/Sales | 1.11% | ||
| Interest Coverage | 5.14 | ||
| Cash Conversion | 89.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 7.1 |
F-Score6
WACC9.63%
ROIC/WACC1
Cap/Depr(3y)60.07%
Cap/Depr(5y)110.25%
Cap/Sales(3y)3.16%
Cap/Sales(5y)3.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.77%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%34.69%
EPS Next Y30.61%
EPS Next 2Y18.45%
EPS Next 3Y16.36%
EPS Next 5Y12.11%
Revenue 1Y (TTM)-16.03%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-26.44%
Revenue Next Year-27.11%
Revenue Next 2Y-11.76%
Revenue Next 3Y-5.71%
Revenue Next 5Y-1.1%
EBIT growth 1Y9.5%
EBIT growth 3Y-45.85%
EBIT growth 5Y-27.67%
EBIT Next Year41.66%
EBIT Next 3Y17.15%
EBIT Next 5Y13.17%
FCF growth 1Y423.12%
FCF growth 3Y-14.18%
FCF growth 5Y-0.52%
OCF growth 1Y1898.08%
OCF growth 3Y-9.48%
OCF growth 5Y-2.39%
MASIMO CORP / MASI FAQ
What is the fundamental rating for MASI stock?
ChartMill assigns a fundamental rating of 4 / 10 to MASI.
Can you provide the valuation status for MASIMO CORP?
ChartMill assigns a valuation rating of 5 / 10 to MASIMO CORP (MASI). This can be considered as Fairly Valued.
Can you provide the profitability details for MASIMO CORP?
MASIMO CORP (MASI) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for MASI stock?
The Price/Earnings (PE) ratio for MASIMO CORP (MASI) is 24.28 and the Price/Book (PB) ratio is 9.14.
Can you provide the financial health for MASI stock?
The financial health rating of MASIMO CORP (MASI) is 6 / 10.